Primary tabs

Friday, September 22, 2023 - 17:00 to 20:30
The Nippon Club (145 West 57th Street, New York, NY 10019) Invite only

Join us for a lively discussion on how Japan can contribute to the fight against communicable diseases in the post-COVID world.

Bringing together representatives from international organizations, government officials, the private sector and civil society, this event will highlight how we can tackle future pandemic by looking into the synergies we can expect from the current pandemic (tuberculosis) response.

The discussion here will be taken back to the 10th Nikkei FT Communicable Diseases Conference, to be held in Tokyo on 16-18 October 2023, to develop and translate into concrete action plans.


Participation will be onsite in New York only. (No online sessions will be held.)

We look forward to your participation.


Please register

Please note that a lottery may be held if the total number of enrolled applicants exceeds the number of seats available.

Event Topic “Ongoing pandemic (tuberculosis) response and future pandemic preparedness – How to make synergy.”

Date and Time:September 22, 2023

17:00-18:00   Networking Reception

         (Please enjoy Sushi and Sake while networking)

18:00-18:15   Opening Remarks

         Shigeru OMI, Chairman, Japan Anti-Tuberculosis Association (JATA)

18:15-20:15   Panel Discussion (18:15-20:15)

         Moderator: Osamu KUNII, CEO, Global Health Innovative Technology Fund(GHIT Fund)


            Lucica DITIU, Executie Director, Stop TB Partnership

            Richard HATCHETT, CEO, CEPI

            Willo BROCK, Executive Vice President, External Affairs, FIND

            Rachel M. COHEN, Senior Advisor, Global Policy Advocacy & Access, Drugs for Neglected Diseases initiative (DNDi)

            Olya KLYMENKO, Chairperson of the Board, TB Survivor in Ukraine,

            Eliud WANDWALO, Head of Tuberculosis, Technical Advice and Partnerships Department, Global Fund

            Masataka AKIYAMA, Director, Corporate Vice President, General Manager, Medical Systems Business Div., Fujifilm Corporation

            Teik Jun BEH, Clinical Strategy Director, Remedy & Company Corporation

            Eiji HINOSHITA, Assistant Minister for Global Health and Welfare, Japanese Ministry of Health, Labour and Welfare

            Seiya KATO, Director, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (RIT/JATA)

            Akira SHIMOUCHI, Project Director “Strengthening Urban TB Control Program in Kathmandu”, JATA Nepal Office [video message]

            Mathume Joseph PHAAHLA, Minister of Health, Govt. of South Africa (tbc)

            Ibrahim ABUBAKAR, Dean, Faculty of Population Health Sciences, University College London

20:15-20:30   Closing Remarks

Organizers:Nikkei Inc.

Co-Organizer: Global Health Innovative Technology Fund (GHIT Fund), Government of Japan and Stop TB Partnership

Sponsor: Japan Airlines